Loading...
XNAS
BLFS
Market cap1.24bUSD
Dec 04, Last price  
25.83USD
1D
1.25%
1Q
-2.38%
Jan 2017
1,504.05%
Name

BioLife Solutions Inc

Chart & Performance

D1W1MN
XNAS:BLFS chart
P/E
P/S
15.12
EPS
Div Yield, %
Shrs. gr., 5y
18.81%
Rev. gr., 5y
24.62%
Revenues
82m
-42.59%
614,718603,219972,2621,322,4971,581,6002,081,5652,758,7295,662,9908,949,4016,190,6986,448,9108,227,00011,022,00019,742,00027,371,00048,087,000119,156,000161,759,000143,271,00082,254,000
Net income
-20m
L-69.61%
-619,323-1,134,018-2,851,774-2,775,117-2,768,352-1,983,630-1,956,639-1,659,586-1,084,160-3,217,750-4,213,936-6,875,000-2,515,0003,266,00011,062,0002,667,000-8,383,000-139,805,000-66,427,000-20,184,000
CFO
8m
P
-576,333-712,196-2,708,979-2,113,418-2,413,642-1,252,526-989,917854,934146,007-3,162,316-4,973,861-4,327,000605,0002,348,0001,213,0006,515,000-4,836,000-8,489,000-12,498,0008,431,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
IPO date
Nov 22, 1989
Employees
466
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT